Current diagnostic methods for infectious diseases often suffer from slow turnaround times, limiting the ability of healthcare providers to make immediate and informed treatment decisions. Delays in pathogen identification can lead to inappropriate antibiotic use, increased healthcare costs, and poorer patient outcomes.

PhAST Diagnostics is developing rapid diagnostic technology designed for the swift identification of infectious agents, providing actionable results in a timely manner. Their approach aims to accelerate the diagnostic process, enabling healthcare providers to make informed decisions more quickly. By reducing the time required for pathogen detection, PhAST Diagnostics seeks to improve patient care, reduce unnecessary antibiotic use, and lower healthcare costs associated with delayed diagnoses.

Advanced pathogen detection methods for rapid identification of infectious agents

Technology designed to deliver timely and actionable results

The primary audience includes healthcare providers who require rapid and accurate diagnostic information to make informed treatment decisions for patients with infectious diseases.